Skip to main content
Caplight Logo









Protera Biosciences

Protera Biosciences

Private
ParisHealthcare & Life Scienceshttps://www.proterabio.com/

Last Round

Series A

Jul 28, 2021

Total Funding Raised

$15.6M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Protera Biosciences is a biotechnology company that utilizes an AI-driven platform, madi™, to engineer and design new proteins for various applications, including food, agriculture, and human health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Infrastructure

Keywords

computational biologyprotein engineeringsynthetic biologyfood technologyclean-label ingredientsprecision fermentationprotein designgenerative AIfood techshelf-life extensionplant-based ingredientsSaaSdeep learningalternative proteinsbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Protera Biosciences Comparables

Compare Protera Biosciences with similar companies based on industry and business-model similarity.

Protera Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shiru
84%
The Live Green Co
79%
Nuritas
78%

Protera Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 28, 2021
Series AJun 9, 2020

Key People

Founding team and executive leadership

Francia Navarrete Utreras

COO And Co-Founder

Founding Team

Franck Leyze

Chief Executive Officer

Executive Team

Leonardo Alvarez

CEO Founder

Founding Team

Protera Biosciences Investors

Notable investors and investment history

Protera Biosciences investors
InvestorRounds
ICL Planet Startup HubSeries A
Grupo BimboSeries A
IndieBioAccelerator
Sofinnova PartnersSeries A
SOSVSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 485% MoM, from 581 to 3.4K.

Protera Biosciences Filings

Explore SEC and related filing metadata, where available.

Protera Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Protera Biosciences's valuation, stock price, and market status.

Is Protera a public or private company?

Protera is a private company.

What is the current stock price of Protera?

Protera is a private company with no public stock price. No recent secondary market data is available.

How much is Protera worth (valuation)?

Valuation information for Protera is not publicly available.

Can I buy Protera stock?

Protera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Protera's last funding round?

Protera's most recent funding round was Series A Extension on July 28, 2021.

Who are the main investors in Protera?

Key investors in Protera include Sofinnova Partners.

Will Protera IPO soon?

No public IPO plans have been announced for Protera.

How can I track Protera secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Protera's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range12
Year Founded2015
Last FundingJul 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?